E. M. Dennison C. Cooper 0 ) MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital , Southampton SO16 6YD, UK - The National Institute of Clinical Excellence
. Dennison (Principal Investigator), C. Cooper, M.H. Edwards. Compliance with ethical standards Ethical approval All procedures performed in studies involving human participants were in accordance with the
James C. Cooper 0 William E. Kovacic 0 0 J. C. Cooper Law & Economics Center, George Mason University School of Law , Arlington, VA, USA Behavioral economics (BE) examines the implications for
GlaxoSmithKline Research and Development , London, UK 1 C. Cooper MRC Lifecourse Epidemiology Unit, University of Southampton , Southampton, UK 2 UK Biobank Musculoskeletal Advisory Group: Chair : Cyrus Cooper (MRC
The enteric nervous system arises from neural crest-derived cells (ENCCs) that migrate caudally along the embryonic gut. The expression of ion channels by ENCCs in embryonic mice was investigated using a PCR-based array, RT-PCR and immunohistochemistry. Many ion channels, including chloride, calcium, potassium and sodium channels were already expressed by ENCCs at E11.5. There was ...
, VA Palo Alto Health Care System , Palo Alto, CA , USA 1 D. C. Cooper 2 HSR&D, VA Puget Sound Health Care System , 1100 Olive Way, Suite 1400, Seattle, WA 98101 , USA 3 D. C. Cooper ( 4 K. M. Nelson 5 R
Kynurenic acid (KYNA), a classical ionotropic glutamate receptor antagonist is also purported to block the α7-subtype nicotinic acetylcholine receptor (α7* nAChR). Although many published studies cite this potential effect, few have studied it directly. In this study, the α7*-selective agonist, choline, was pressure-applied to interneurons in hippocampal subregions, CA1 stratum ...
, Sweden 4 E. V. McCloskey Academic Unit of Bone Metabolism, Northern General Hospital, University of Sheffield , Sheffield, UK 5 J. Stenmark International Osteoporosis Foundation , Nyon, Switzerland 6 C
Briefing , July 2003 2 ) Academic Unit of Bone Metabolism, University of Sheffield , Sheffield S5 7AU, UK 3 C. Cooper MRC Epidemiology Resource Centre, University of Southampton , Southampton, UK - The
, Stockholm, Sweden 4 E. V. McCloskey Academic Unit of Bone Metabolism, Northern General Hospital , Sheffield, UK 5 J. Stenmark International Osteoporosis Foundation , Nyon, Switzerland 6 C. Cooper NIHR ... Musculoskeletal Biomedical Research Unit, Institute of Musculoskeletal Sciences, University of Oxford , Oxford, UK 7 C. Cooper MRC Lifecourse Epidemiology Unit, University of Southampton , Southampton, UK 8 C
Background Switch therapy is a management approach combining early discontinuation of intravenous (IV) antibiotics, switch to oral antibiotics, and early hospital discharge. This analysis compares switch therapy using tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia (CAP). Methods A prospective, randomized, double-blind, Phase 3 clinical ...
that might induce tolerance. David K. C. Cooper Advance Access publication 5 August 2006 Sir, We appreciate Coopers opinion, which is based on a large experience in the field. Undoubtedly, major progress
Southampton , Southampton, UK 4 C. Cooper NIHR Musculoskeletal Biomedical Research Unit, University of Oxford , Oxford, UK 5 A. R. McLellan Gardiner Institute, Western Infirmary , Glasgow, UK 6 P. J. Mitchell
Background Defects in tight junctions, gate-keepers of the integrity of the epidermal barrier function, are known to contribute to cancer development. As such, enhancing our understanding of how the expression of proteins involved in these junctions is regulated in cancer, remains a priority. Although the expression of one of these proteins, claudin 1, is down regulated in most ...
, London , UK 8 A. Diez-Perez Servicio de Medicina Interna y Enfermedades Infecciosas, Hospital del Mar-IMIM and RETICEF , Barcelona , Spain 9 C. Cooper NIHR Musculoskeletal Biomedical Research Unit
M. C. Cooper et al. 0 Department of Physics and Astronomy, University of Pittsburgh , 401-C Allen Hall, 3941 O'Hara Street, Pittsburgh, PA 15260, USA 1 Max-Planck-Institut fur Astronomie , Konigstuhl
Summary The aim of this study was to evaluate fracture risk after onset of myasthenia gravis using the UK General Practice Research Database. Overall fracture risk is not statistically increased compared with age- and gender-matched controls irrespective of glucocorticoid use, but was increased in those using antidepressants, anxiolytics or anticonvulsants. Introduction Myasthenia ...